reports
- Hybridan Team
- Jon Levinson
Hybridan Small Cap Feast: 29/01/2025
Banquet Buffet**** Angle 15.25p £42.75m (AGL.L) The innovative liquid biopsy Company with circulating tumour cell (CTC) solutions for research, drug development and clinical oncology reports successful trial results. Its dual circulating tumour DNA (ctDNA) and CTC-DNA workflow used, for the first time, an end-to-end Illumina solution for analysis. In the study, CTCs were isolated and harvested using the Parsortix system from a single blood tube taken from 27 lung cancer patients. CTCs and ...
- Robin Savage
Litigation Capital Management (LIT LN) - Positive trading update
Litigation Capital Management “LCM” has released a trading update ahead of its full year results to 30 June 2024, on 19 September. We set out the full trading update on pages 2 and 3 of this note. Our highlights are: • Current portfolio continues to perform in line with expectations • In excess of A$250m new commitments were secured in the year (FY23: A$176m) • 8 realisations in the period, of which 6 were Binding Settlements on direct balance sheet investments and 2 were f...
Hybridan Small Cap Feast - 18 June 2024
18th June 2024 * A corporate client of Hybridan LLP ** Arranged by type of listing and date of announcement *** Alphabetically arranged **** Potential means Intention to Float (ITF) has been announced, or it is a rumour Dish of the day Admissions: Advanced Oxygen Therapy Inc (AOTI.L) The medical technology group with a proprietary therapy for the reduction in hospitalisations and amputations caused by non-healing wounds, particularly diabetic foot ulcers, announces its first day of trading on th...
- Robin Savage
Hybridan Small Cap Feast - 10 Jan 24
10th January 2024 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment obje...
- Ed Stacey
Litigation Capital Management:Initiation of Coverage
Litigation Capital Management (LCM) is an alternative asset manager specialising in disputes financing, with its main operations in Australia and the UK. The company provides funding for litigation in exchange for a share of any settlement and has built a strong track record of supporting winning c
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.